Dr. Brandt is the co-founder of vivoPharm. He is a biochemist and cell biologist with over 15 years experience in research programs of experimental oncology. Furthermore, he has immense experience in in vivo pharmacology and anti-cancer drug profiling. He received his Licence (BSc in Biochemistry and Animal Physiology) in 1986, and his PhD (in Biochemistry) in 1991 from the Martin-Luther University of Halle-Wittenberg, Germany. Dr. Brandt was employed at research positions at the National Cancer Institute in Bethesda, MD, USA and at Schering AG, Germany. Since 1990, Dr. Brandt has been active in the field of preclinical oncology. He led the Tumour Biology program at Novartis Pharma AG, Switzerland and established several transgenic mouse lines developing tumours under the control of oncogenes. During Dr. Brandt's long career in the pharmaceutical industry he has acquired significant knowledge and expertise in leading business units and representation of services to the pre-clinical research market. Dr. Brandt is a member of the Scientific Advisory Board at Receptor Inc. in Toronto Canada
Back to Top
Mrs Sabine Brandt is a co-founder of vivoPharm. Her career, which has spanned close to 10 years, includes financial management, financial planning and sales in a variety of industry sectors such as insurance and banking. In these roles, Mrs Brandt has gained experience within various departments of the banking and financial markets in Germany. Mrs Brandt led in the establishment of new offices for some insurance companies which has brought her a high level of experience in accounting and sales.
Back to Top
Dr Mackenzie joined vivoPharm in 2010 as Vice President for Research and Science with over 30 years experience in scientific project development and model establishment. She has worked extensively in the areas of neuroscience, cancer and cardiac research. Dr Mackenzie graduated from Flinders University of South Australia in 1996 with a Bachelor of Science Degree with a triple major in Molecular Biology, Microbiology and Genetics and again in December 2003 with a PhD where she evaluated the electrophysiological pathophysiology of epilepsy. For her post doctoral studies she was awarded a prestigious Peter Doherty Fellowship from NHMRC and moved to University of Adelaide where she spent 7 Years as a Senior Research Fellow establishing and leading the Experimental Electrophysiology Laboratory conducting cardiac research. Dr Mackenzie has published extensively with over 40 peer reviewed original journal articles and has won many awards including the Ahrens Award for Excellence in 2010 from the Heart Foundation.
